M Allez

Summary

Country: France

Publications

  1. doi request reprint [Practical use of anti-TNF monoclonal antibodies in inflammatory bowel diseases]
    M Allez
    Service de Gastroenterologie, Hopital Saint Louis, AP HP, Universite Paris 7 Denis Diderot, 2, place Jussieu, 75005 Paris, France
    Gastroenterol Clin Biol 32:467-77. 2008
  2. doi request reprint The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies
    M Allez
    Hopital Saint Louis, APHP, Universite Paris 7, Paris, France
    Aliment Pharmacol Ther 31:92-101. 2010
  3. doi request reprint Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects
    Matthieu Allez
    Department of Gastroenterology, Hopital Saint Louis, APHP, Universite Paris 7 Denis Diderot, France Equipe Avenir INSERM U940, France
    J Crohns Colitis 4:355-66. 2010
  4. pmc Role of endoscopy in predicting the disease course in inflammatory bowel disease
    Matthieu Allez
    Department of Gastroenterology, Saint Louis Hospital, APHP, Universite Denis Diderot Paris 7, 75010 Paris, France
    World J Gastroenterol 16:2626-32. 2010
  5. ncbi request reprint CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions
    Matthieu Allez
    Service de Gastroenterologie, Hopital Saint Louis, Paris, France INSERM Unité 662, Hopital Saint Louis, Paris, France
    Gastroenterology 132:2346-58. 2007
  6. ncbi request reprint Hydrostatic balloon dilatation of Crohn's strictures
    J M Sabate
    Department of Gastroenterology, Hopital Saint Louis, Paris, France
    Aliment Pharmacol Ther 18:409-13. 2003
  7. ncbi request reprint Azathioprine for prevention of postoperative recurrence in Crohn's disease: a retrospective study
    E Cuillerier
    Department of Gastroenterology, Saint-Louis Hospital, Paris, France
    Eur J Gastroenterol Hepatol 13:1291-6. 2001
  8. ncbi request reprint An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease
    J M Sabate
    Department of Gastroenterology, Hospital Saint Louis, 1 avenue Claude Vellefaux, 75010 Paris, France
    Aliment Pharmacol Ther 16:1117-24. 2002
  9. doi request reprint IFNgamma and antibody responses among French nurses during a tuberculosis contact tracing investigation
    J L Herrmann
    Microbiology Department, Raymond Poincare Hospital, 104 boulevard Raymond Poincaré, 92380 Garches, France
    Pathol Biol (Paris) 57:e49-53. 2009
  10. doi request reprint [Prolonged acute pancreatitis after bone marrow transplantation]
    B De Singly
    Service de Gastroenterologie, Hopital Saint Louis, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France
    Gastroenterol Clin Biol 32:413-6. 2008

Collaborators

Detail Information

Publications16

  1. doi request reprint [Practical use of anti-TNF monoclonal antibodies in inflammatory bowel diseases]
    M Allez
    Service de Gastroenterologie, Hopital Saint Louis, AP HP, Universite Paris 7 Denis Diderot, 2, place Jussieu, 75005 Paris, France
    Gastroenterol Clin Biol 32:467-77. 2008
  2. doi request reprint The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies
    M Allez
    Hopital Saint Louis, APHP, Universite Paris 7, Paris, France
    Aliment Pharmacol Ther 31:92-101. 2010
    ..Adalimumab (ADA) and certolizumab pegol (CZP) have demonstrated efficacy in Crohn's disease (CD) patients previously treated with infliximab (IFX)...
  3. doi request reprint Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects
    Matthieu Allez
    Department of Gastroenterology, Hopital Saint Louis, APHP, Universite Paris 7 Denis Diderot, France Equipe Avenir INSERM U940, France
    J Crohns Colitis 4:355-66. 2010
    ....
  4. pmc Role of endoscopy in predicting the disease course in inflammatory bowel disease
    Matthieu Allez
    Department of Gastroenterology, Saint Louis Hospital, APHP, Universite Denis Diderot Paris 7, 75010 Paris, France
    World J Gastroenterol 16:2626-32. 2010
    ..More specifically, we discuss how endoscopy can be used at different stages of IBD to predict the disease course and/or to adapt treatment strategies...
  5. ncbi request reprint CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions
    Matthieu Allez
    Service de Gastroenterologie, Hopital Saint Louis, Paris, France INSERM Unité 662, Hopital Saint Louis, Paris, France
    Gastroenterology 132:2346-58. 2007
    ..We examined the role of MICA-NKG2D interactions in the activation of T lymphocytes in CD...
  6. ncbi request reprint Hydrostatic balloon dilatation of Crohn's strictures
    J M Sabate
    Department of Gastroenterology, Hopital Saint Louis, Paris, France
    Aliment Pharmacol Ther 18:409-13. 2003
    ..To evaluate the safety and long-term efficacy of per-endoscopic hydrostatic balloon dilatation in a retrospective series of patients with Crohn's disease...
  7. ncbi request reprint Azathioprine for prevention of postoperative recurrence in Crohn's disease: a retrospective study
    E Cuillerier
    Department of Gastroenterology, Saint-Louis Hospital, Paris, France
    Eur J Gastroenterol Hepatol 13:1291-6. 2001
    ..Our results suggest that AZA should be evaluated prospectively for prevention of postoperative CD recurrence, at least in high-risk patients...
  8. ncbi request reprint An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease
    J M Sabate
    Department of Gastroenterology, Hospital Saint Louis, 1 avenue Claude Vellefaux, 75010 Paris, France
    Aliment Pharmacol Ther 16:1117-24. 2002
    ..Infliximab, a chimeric monoclonal antibody to tumour necrosis factor-alpha, is a new potent therapy for active Crohn's disease, but induces short-lived improvements...
  9. doi request reprint IFNgamma and antibody responses among French nurses during a tuberculosis contact tracing investigation
    J L Herrmann
    Microbiology Department, Raymond Poincare Hospital, 104 boulevard Raymond Poincaré, 92380 Garches, France
    Pathol Biol (Paris) 57:e49-53. 2009
    ....
  10. doi request reprint [Prolonged acute pancreatitis after bone marrow transplantation]
    B De Singly
    Service de Gastroenterologie, Hopital Saint Louis, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France
    Gastroenterol Clin Biol 32:413-6. 2008
    ..Pancreatic GVHD diagnosis was performed after five weeks on duodenal biopsies despite the absence of diarrheoa. The patient dramatically improved within few days on corticosteroids...
  11. pmc Chronic diarrhoea after allogenic bone marrow transplantation
    B Radu
    Service de Gastroenterologie, Hopital Saint Louis, 1 avenue Claude Vellefaux, F75010, Paris, France
    Gut 54:161, 174. 2005
  12. doi request reprint [Colonic lipoma: case report and literature review]
    N Goasguen
    Service de Chirurgie Generale, digestive et endocrinienne, Hopital Saint Louis, 1, avenue Claude Vellefaux, 75010 Paris, France
    Gastroenterol Clin Biol 32:521-4. 2008
    ..The diagnosis was confirmed by histological examination. Reviewing the literature and combining with our experience, we discuss the clinical features, diagnosis and treatment of this uncommon disease...
  13. ncbi request reprint Recurrent cholestatic jaundice associated with generalized pustular psoriasis: evidence for a neutrophilic cholangitis
    M Allez
    Service d Hepato Gastroenterologie, Hopital Saint Louis, Paris, France
    J Hepatol 33:160-2. 2000
    ..Ultrasonographic exams and retrograde cholangiography ruled out biliary tract disease. This observation suggests that recurring cholestatic jaundice in pustular psoriasis is related to a neutrophilic cholangitis...
  14. doi request reprint Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis
    S Leblanc
    Hopital Saint Louis, Universite Paris Diderot, Assistance Publique Hopitaux de Paris, Paris, France
    Am J Gastroenterol 106:771-7. 2011
    ..The aims of this study were to investigate the efficacy and tolerance of IFX and CYS as a second-line rescue therapy in steroid-refractory UC or indeterminate colitis (IC) unsuccessfully treated with CYS or IFX...
  15. ncbi request reprint Fate of the rectum in patients undergoing total colectomy for Crohn's disease
    P Cattan
    Department of Digestive Surgery, Hopital Saint Louis, Paris, France
    Br J Surg 89:454-9. 2002
    ..This study aimed to analyse disease recurrence and fate of the rectum in patients who had a total colectomy for Crohn's disease...
  16. ncbi request reprint [Infliximab therapy for Crohn's disease anoperineal lesions]
    A Ouraghi
    , CHU, Lille, France
    Gastroenterol Clin Biol 25:949-56. 2001
    ..CONCLUSION: Remicade is rapidly effective and well tolerated in anoperineal Crohn's lesions, but the high relapse rate stresses the need for long term therapeutic strategies in these patients...